Drug recall · February 19, 2014
Diclofenac Sodium and Misoprostol Delayed-Release Tablets recall
Why: Failed Tablet/Capsule Specifications: Split tablets were found in the 12-month stability samples.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Diclofenac Sodium and Misoprostol Delayed-Release Tablets, 75 mg/0.2 mg, 60-count bottle, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA 92880, NDC 0591-0398-60, UPC 3 05910 39860 6.
- Lots / codes
Lot# 605957A, Exp 09/14
- Quantity
- 5987 bottles
- Company
- Watson Laboratories, Inc.-(Actavis) - Florida, Davie, FL
- Distribution
- Nationwide
- Initiated
- December 20, 2013 · Voluntary: Firm initiated
- Classified
- February 7, 2014
- Reported
- February 19, 2014
- Ended
- September 17, 2014
- How notified
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Diclofenac / misoprostol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.